An in vivo quantitative structure-activity relationship for a congeneric series of pyropheophorbide derivatives as photosensitizers for photodynamic therapy

Cancer Research

Volumn 57, Issue 18, 1997, Pages 4000-4007

  Henderson, Barbara W ^a   Bellnier, David A ^a   Greco, William R ^a   Sharma, Amarnath ^a   Pandey, Ravindra K ^a   Vaughan, Lurine A ^a   Weishaupt, Kenneth R ^a   Dougherty, Thomas J ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PHORBOL DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; IN VIVO STUDY; LIPOPHILICITY; MICROVASCULATURE; MOUSE; NONHUMAN; PHOTODYNAMIC THERAPY; PHOTOSENSITIZATION; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION; TISSUE DISTRIBUTION; TUMOR GROWTH; TUMOR LOCALIZATION;

ANIMALS; ANTINEOPLASTIC AGENTS; CHLOROPHYLL; FEMALE; LIPIDS; MICE; MICE, INBRED C3H; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; REGIONAL BLOOD FLOW; SOLUBILITY; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0030774313     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Dougherty, T. J. Photodynamic therapy. Photochem. Photobiol., 58: 895-900, 1993.
2. Pass, H. I. Photodynamic therapy in oncology: mechanisms and clinical use. J. Natl. Cancer Inst., 85: 443-456, 1993.
3. Fisher, A. M. R., Murphree, A. L., and Gomer, C. J. Clinical and preclinical photodynamic therapy. Lasers Surg. Med., 17: 2-32, 1996.
4. Henderson, B. W., and Dougherty, T. J. How does photodynamic therapy work? Photochem. Photobiol., 55: 145-157, 1992.
5. Pandey, R. K., Siegel, M. M., Tsao, R., McReynolds, J. H., and Dougherty, T. J. Fast atom bombardment mass spectral analyses of Photofrin II and its synthetic analogs. Biomed. Environ. Mass. Spectrom., 19: 405-414, 1990.
6. Bellnier, D. A., Henderson, B. W., Pandey, R. K., Potter, W. R., and Dougherty, T. J. Murine pharmacokinetics and antitumor efficacy of the photodynamic sensitizer 2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a. J. Photochem. Photobiol. B Biol., 20: 55-61, 1993.
7. Payne, J. T., McCaw, D. L., Casteel, S. W., Frazier, D., Rogers, K., and Tompson, R. V. Pharmacokinetics of pyropheophorbide-a-hexyl ether in the dog. Lasers Surg. Med., 18: 406-409, 1996.
8. Kubinyi, H. Lipophilicity and biological activity: drug transport and drug distribution in model systems and in biological systems. Arzneim.-Forsch., 29: 1067-1080, 1979.
9. Pandey, R. K., Sumlin, A. B., Constantine, S., Aoudia, M., Potter, W. R., Bellnier, D. A., Henderson, B. W., Rodgers, M. A., Smith, K. M., and Dougherty, T. J. Alkyl ether analogs of chlorophyll-a derivatives: part 1. Synthesis, photophysical properties and photodynamic efficacy. Photochem. Photobiol., 64: 194-204, 1996.
10. Baker, J. K., Rauls, D. O., and Borne, R. F. Correlation of biological activity and high-pressure liquid chromatographic retention index for a series of propranolol, barbiturate, and anthranilic acid analogues. J. Med. Chem., 22: 1301-1306, 1979.
11. Henry, D., Block, J. H., Anderson, J. L., and Carlson, G. R. Use of high-pressure liquid chromatography for quantitative structure-activity relationship studies of sulfonamides and barbiturates. J. Med. Chem., 19: 619-626, 1976.
12. Margaron, P., Gregoire, M., Scasnar, V., Ali, H., and van Lier, J. E. Structure-photodynamic activity relationships of a series of 4-substituted zinc phthalocyanines. Photochem. Photobiol., 63: 217-223, 1996.
13. Twentyman, P. R., Brown, J. M., Gray, J. W., Franko, A. J., Scoles, M. A., and Kallman, R. F. A new mouse tumor model system (RIF-1) for comparison of end-point studies. J. Natl. Cancer Inst., 64: 595-604, 1980.
14. Henderson, B. W., Waldow, S. M., Mang, T. S., Potter, W. R., Malone, P. B., and Dougherty, T. J. Tumor destruction and kinetics of tumor cell death in two experimental mouse tumors following photodynamic therapy. Cancer Res., 45: 572-576, 1985.
15. Kaplan, E. L., and Meier, P. Nonparametric estimation from incomplete observations. J. Amer. Statist. Assoc., 53: 457-481, 1958.
16. Cox, D. R. Regression models and life tables. J. Roy. Statist. Soc., 34B: 187-220, 1972.
17. Hill, A. V. The possible effects of the aggregation of the molecules of haemoglobin on its dissociation curves. J. Physiol., 40: iv-vii, 1910.
18. Bellnier, D. A., Potter, W. R., Vaughan, L. A., Parsons, J. C., Greco, W. R., and Henderson, B. W. The validation of a new vascular damage assay for photodynamic therapy agents. Photochem. Photobiol., 62: 896-905, 1995.
19. Higuchi, T., and Davis, S. S. Thermodynamic analysis of structure-activity relationships of drugs: prediction of optimal structure. J. Pharm. Sci., 59: 1376-1383, 1970.
20. Bellnier, D. A., Greco, W. R., Parsons, J. C., Oseroff, A. R., Kuebler, A., and Dougherty, T. J. An assay for the quantitation of Photofrin® in tissues and fluids. Photochem. Photobiol., 66: 1997.
21. Fingar, V. H., and Henderson, B. W. Drug and light dose dependence of photodynamic therapy: a study of tumor and normal tissue response. Photochem. Photobiol., 46: 837-841, 1987.
22. Chung, F., Morse, M. A., and Elkind, K. I. New potential chemopreventive agents for lung carcinogenesis of tobacco-specific nitrosamine. Cancer Res., 52: 2719-2722, 1992.
23. Jiao, D., Elkind, K. I., Choi, C., Desai, D. H., Amin, S. G., and Chung, F. Structure-activity relationships of isothiocyanates as mechanism-based inhibitors of 4-(methylnitrosamino)-1-(3-pyridyl) - 1-butanone-induced lung tumorigenesis in A/J mice. Cancer Res., 54: 4327-4333, 1994.
24. Toon, S., and Rowland, M. Structure-pharmacokinetic relationships among the barbiturates in the rat. J. Pharmacol. Exp. Ther., 225: 752-762, 1983.
25. Dearden, J. C. Partitioning and lipophilicity in quantitative structure-activity relationships Environ. Health Perspect., 61: 203-228, 1985.
26. Aarons, L., Bell, D., Waigh, R., and Ye, Q. Parabolic structure-activity relationships: a simple pharmacokinetic model. J. Pharm. Pharmacol., 34: 746-749, 1982.
27. Cooper, E. R., Berner, B., and Bruce, R. D. Kinetic analysis of relationship between partition coefficient and biological response. J. Pharm. Sci., 70: 57-59, 1981.
28. Aveline, B. M., Hasan, T., and Redmond, R. W. The effects of aggregation, protein binding and cellular incorporation on the photophysical properties of benzoporphyrin derivative monoacid ring A (BPDMA). J. Photochem. Photobiol. B Biol., 30: 161-169, 1995.
29. Richter, A. M., Kelly, B., Chow, J., Liu, D. J., Towers, G. H., Dolphin, D., Levy, J. G. Preliminary studies on a more effective phototoxic agent than hematoporphyrin. J. Natl. Cancer Inst., 79: 1327-1332, 1987.
30. Woodburn, K. W., Vardaxis, N. J., Hill, J. S., Kaye, A. H., Reiss, J. A., and Phillips, D. R. Evaluation of porphyrin characteristics required for photodynamic therapy. Photochem. Photobiol., 55: 697-704, 1992.
31. Pandey, R. K., Potter, W. R., Meunier, I., Sumlin, A. B., and Smith, K. M. Evaluation of new benzoporphyrin derivatives with enhanced PDT efficacy. Photochem. Photobiol., 62: 764-768, 1995.
32. Richter, A. M., Waterfield, E., Jain, A. K., Allison, B., Sternberg, E. D., Dolphin, D., and Levy, J. G. Photosensitising potency of structural analogues of benzoporphyrin derivative (BPD) in a mouse tumour model. Br. J. Cancer. 63: 87-93, 1991.